SFDA-2023-0037-V137
Major variation for application SFDA-2023-0037. Major variation: Shelf Life Extension for Thymosilib — minor update
Variation Number
SFDA-2023-0037-V137
Type
Major
Application
Change
Status
Draft
Fee
€10,969
Submitted
2023-08-13
Approved
—
Description
Major variation: Shelf Life Extension for Thymosilib — minor update